Many neurodegenerative diseases—including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Huntington’s disease—are strongly linked to chronic inflammation within the central nervous system (CNS). This review examines how cannabinoids interact with both the nervous and immune systems and explores their potential role in reducing inflammation that contributes to nerve cell damage. Researchers highlight that […]
Category: Alzheimer’s
Phytocannabinoids and Brain Health: Early Evidence in Parkinson’s and Alzheimer’s Models (pub. June 2025)
Neurodegenerative diseases such as Parkinson’s and Alzheimer’s involve the progressive loss of nerve cells, leading to movement problems, memory decline, and cognitive challenges. Because current treatments often only ease symptoms, researchers are exploring whether phytocannabinoids—naturally occurring compounds from the Cannabis sativa plant—might influence the biological processes behind these disorders. This review article summarizes recent preclinical […]
Cannabidiol (CBD) and Neurodegeneration: What Research Says About Brain Health Support (pub. July 2024)
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s, multiple sclerosis, and ALS involve the progressive loss of neurons, leading to declines in memory, movement, and overall brain function. These conditions are linked to factors like aging, chronic inflammation, oxidative stress, and abnormal protein buildup in the brain. Traditional treatments often provide only short‑term symptom relief and […]